CST3 and chronic kidney disease: Traditional obstacles to CKD testing, such as the limited time and resources faced by primary care providers,10 could be exacerbated by specific barriers related to cystatin C. In this study, we assessed the current awareness and experience of health care professionals with cystatin C-based eGFR testing, with a focus on primary care providers.